The shares of Dynavax Technologies Corporation (NASDAQ:DVAX) has been pegged with a rating of Buy by H.C. Wainwright in its latest research note that was published on October 18, 2019. The Healthcare company has also assigned a $13 price target. H.C. Wainwright wasn’t the only research firm that published a report of Dynavax Technologies Corporation, with other equities research analysts also giving their opinion on the stock. Cantor Fitzgerald advised investors in its research note published on July 11, 2019, to Overweight the DVAX stock while also putting a $20 price target. The stock had earned Overweight rating from Cantor Fitzgerald Markets when it published its report on February 27, 2019. That day the Cantor Fitzgerald set price target on the stock to $28. Cantor Fitzgerald was of a view that DVAX is Overweight in its latest report on March 08, 2018. JP Morgan thinks that DVAX is worth Neutral rating.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 0 believe it has the potential for further growth, thus rating it as Hold while 3 advised investors to purchase the stock. The consensus currently stands at a Buy while its average price target is $14.00. The price of the stock the last time has raised by 98.33% from its 52-Week high price while it is -56.41% than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 52.56.
The shares of the company added by 5.00% during the trading session on Monday, reaching a low of $3.405 while ending the day at $3.57. During the trading session, a total of 2.77 million shares were traded which represents a -76.27% decline from the average session volume which is 1.57 million shares. DVAX had ended its last session trading at $3.40. Dynavax Technologies Corporation debt-to-equity ratio currently stands at 21.52, while its quick ratio hovers at 3.20 DVAX 52-week low price stands at $1.80 while its 52-week high price is $8.19.
The company in its last quarterly report recorded -$0.34 earnings per share which is below the predicted by most analysts. The Dynavax Technologies Corporation generated 39.88 million in revenue during the last quarter. In the second quarter last year, the firm recorded -$0.49 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -82.35%. Dynavax Technologies Corporation has the potential to record -1.12 EPS for the current fiscal year, according to equities analysts.
Investment analysts at Wells Fargo published a research note on April 17, 2020 where it informed investors and clients that O-I Glass Inc. (NYSE:OI) is now rated as Underweight. Their price target on the stock stands at $7. BofA/Merrill also rated OI as Downgrade on April 13, 2020, with its price target of $9 suggesting that OI could surge by 39.75% from its current share price. Even though the stock has been trading at $6.75/share, analysts expect it to down by -7.70% to reach $10.34/share. It started the day trading at $6.62 and traded between $6.15 and $6.23 throughout the trading session.
A look at its technical shows that OI’s 50-day SMA is 8.78 while its 200-day SMA stands at 10.89. The stock has a high of $20.08 for the year while the low is $4.30. The stock, however, witnessed a rise in its short on 03/31/20. Compared to previous close which recorded 11.28 M shorted shares, the short percentage went lower by -15.08%, as 9.58M DVAX shares were shorted. At the moment, only 6.17% of O-I Glass Inc. shares were sold short. The company’s average trading volume currently stands at 2.90M shares, which means that the short-interest ratio is just 3.30 days. Over the past seven days, the company moved, with its shift of -8.38%. Looking further, the stock has dropped -51.89% over the past 90 days while it lost -35.77% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Russell Investment Management LLC bought more OI shares, increasing its portfolio by 31.25% during the last quarter. This move now sees The Russell Investment Management LLC purchasing 3,624,724 shares in the last quarter, thus it now holds 15,224,358 shares of OI, with a total valuation of $108,245,185. The Vanguard Group, Inc. meanwhile sold more OI shares in the recently filed quarter, changing its stake to $104,905,526 worth of shares.
Similarly, BlackRock Fund Advisors decreased its O-I Glass Inc. shares by 4.82% during the recently filed quarter. After selling 12,749,625 shares in the last quarter, the firm now controls -646,080 shares of O-I Glass Inc. which are valued at $90,649,834. In the same vein, First Pacific Advisors LP decreased its O-I Glass Inc. shares by during the most recent reported quarter. The firm sold 105,540 shares during the quarter which decreased its stakes to 9,996,350 shares and is now valued at $71,074,049. Following these latest developments, around 0.90% of O-I Glass Inc. stocks are owned by institutional investors and hedge funds.